• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN SPIDER FX; TEMPORARY CAROTID CATHETER FOR EMBOLIC CAPTURE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN SPIDER FX; TEMPORARY CAROTID CATHETER FOR EMBOLIC CAPTURE Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Transient Ischemic Attack (2109); Obstruction/Occlusion (2422)
Event Date 09/15/2020
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
A journal article was submitted detailing a clinical trial for government approval of a non-medtronic device in patients at either high or normal risk for carotid endarterectomy.163 patients were included in the study.Medtronic¿s spider fx embolic protection device and mo.Ma ultra cerebral protection device were used 5.7% of cases each.Multiple protection devices were used in 19.3% of procedures.Clinical event¿s of left hemiparesis in one patient which occurred immediately after stent deployment, and the responsible infarction was revealed in the right frontal and occipital lobe, and one patient presented with left hemiparesis 1day after cas where carotid ultrasonography revealed plaque protrusion within the stent, requiring additional stenting with percutaneous transluminal angioplasty the same day.There were no reports of death or mi within 30 days, and no ipsilateral stroke within 1year after the procedure.The tlr rate was 2.4%, and additional treatments were performed 180¿365 days after stent placement in two cases and 1 day after in one case.Cerebrovascular events occurred in 7.2% of cases including ischemic stroke and tia in 2 and 8 cases respectively.Severe stroke resulting in neurological symptoms lasting >7 days and deterioration of the national institutes of health stroke scale (nihss) score occurred on the day of the procedure in one case.Minor stroke, which resolved within 7 days or presented with a deterioration in nihss score was encountered within 1¿30 days in one case.No instances of ipsilateral stroke were recorded between 30 days and 1year.Tias occurred at any time, with 2, 3, and 3 tias occurring on the day of cas, within 1¿30 days, and between 30 days and 1year, respectively.One patient had cranial nerve palsy, but this was a bilateral facial palsy unrelated to the stenting.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPIDER FX
Type of Device
TEMPORARY CAROTID CATHETER FOR EMBOLIC CAPTURE
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
EI  
091708734
MDR Report Key12041556
MDR Text Key257481307
Report Number2183870-2021-00228
Device Sequence Number1
Product Code NTE
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K063204
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 06/22/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/15/2021
Initial Date FDA Received06/22/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age74 YR
-
-